🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)

Recruitingn/aAges 20 Years - 120 YearsAllNational Taiwan University Hospital
NCT06917378 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria 1. Over 20 years old 2. Chronic total occlusion confirmed by coronary angiography, and noted for more than 3 months Exclusion criteria Nil
💊

What it tests

  • Percutaneous coronary intervention of coronary chronic total occlusion
📍

Where

3 sites
Chang Gung Memorial Hospital
New Taipei City, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy